Letter to the editor [1]

Statistics in Medicine

Volumn 24, Issue 10, 2005, Pages 1609-

  Cuzick, Jack ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; COMPUTER PROGRAM; DATA ANALYSIS; DATA BASE; HUMAN; LETTER; PUBLICATION; SCIENTIFIC LITERATURE;

EID: 19144373050     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.2027     Document Type: Letter

References (1)

1. The ATAC Trialists' Group. Anastroloze alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer - results of the ATAC (arimidex, tamoxifen alone or in combination) trial efficacy and safety update analysis. Cancer 2003; 98:1802-1810.